SU‐E‐T‐10: A Computational Model for the Estimation of Biological Dose in a Clinical Proton Beam

I. Das, V. Anferov, A. Besemer, V. Moskvin, D. Nichiporov

Research output: Contribution to journalArticle

Abstract

Purpose: The variability of relative biological effectiveness (RBE) of a proton beam with spatial distribution is well known. It is dependent on the proton beam characteristics, type of tissue and biological indices. A computational model based on a proton spectrum and LET is used for the estimation of the biological dose. Methods: The depth dose curve of the pristine beam is divided into two regions: the proximal region from the surface to the Bragg peak and the distal region beyond the peak. Knowing the beam energy at the surface in the proximal region, and using the published energy‐range tables, we estimated the effective proton energy at any depth proximal to the Bragg peak. Based on the energy, the LET and RBE is estimated. In the distal region, we assume that the effective beam energy changes monotonically from the value calculated at the peak to the final energy of about 3MeV at the 3% dose level on the distal edge. Applying the calculated RBE factor to the measured depth dose profile we obtain the biological dose in the pristine beam. The method can easily be applied to modulated beams. Results: Our computation model shows that it is possible to predict the biological dose for any combination of beam energy, and for SOBP size based on the available RBE data. Our results showed that the biological dose for a SOBP has finite slope rising to higher values close to distal edge of the peak. Conclusions: A computational model provides an unique tool to estimate the biological dose in any combination of beam energy and SOBP size. If the RBE vs LET data for a tissue is know our computational approach could provide the biological dose accurately in a clinical beam.

Original languageEnglish (US)
Number of pages1
JournalMedical physics
Volume38
Issue number6
DOIs
StatePublished - Jun 2011

Fingerprint

Relative Biological Effectiveness
Biological Models
Protons
Linear Energy Transfer
Biological Factors

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

SU‐E‐T‐10 : A Computational Model for the Estimation of Biological Dose in a Clinical Proton Beam. / Das, I.; Anferov, V.; Besemer, A.; Moskvin, V.; Nichiporov, D.

In: Medical physics, Vol. 38, No. 6, 06.2011.

Research output: Contribution to journalArticle

@article{7e65c52168534c0fb3d6a8dddcec9c55,
title = "SU‐E‐T‐10: A Computational Model for the Estimation of Biological Dose in a Clinical Proton Beam",
abstract = "Purpose: The variability of relative biological effectiveness (RBE) of a proton beam with spatial distribution is well known. It is dependent on the proton beam characteristics, type of tissue and biological indices. A computational model based on a proton spectrum and LET is used for the estimation of the biological dose. Methods: The depth dose curve of the pristine beam is divided into two regions: the proximal region from the surface to the Bragg peak and the distal region beyond the peak. Knowing the beam energy at the surface in the proximal region, and using the published energy‐range tables, we estimated the effective proton energy at any depth proximal to the Bragg peak. Based on the energy, the LET and RBE is estimated. In the distal region, we assume that the effective beam energy changes monotonically from the value calculated at the peak to the final energy of about 3MeV at the 3{\%} dose level on the distal edge. Applying the calculated RBE factor to the measured depth dose profile we obtain the biological dose in the pristine beam. The method can easily be applied to modulated beams. Results: Our computation model shows that it is possible to predict the biological dose for any combination of beam energy, and for SOBP size based on the available RBE data. Our results showed that the biological dose for a SOBP has finite slope rising to higher values close to distal edge of the peak. Conclusions: A computational model provides an unique tool to estimate the biological dose in any combination of beam energy and SOBP size. If the RBE vs LET data for a tissue is know our computational approach could provide the biological dose accurately in a clinical beam.",
author = "I. Das and V. Anferov and A. Besemer and V. Moskvin and D. Nichiporov",
year = "2011",
month = "6",
doi = "10.1118/1.3611960",
language = "English (US)",
volume = "38",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "6",

}

TY - JOUR

T1 - SU‐E‐T‐10

T2 - A Computational Model for the Estimation of Biological Dose in a Clinical Proton Beam

AU - Das, I.

AU - Anferov, V.

AU - Besemer, A.

AU - Moskvin, V.

AU - Nichiporov, D.

PY - 2011/6

Y1 - 2011/6

N2 - Purpose: The variability of relative biological effectiveness (RBE) of a proton beam with spatial distribution is well known. It is dependent on the proton beam characteristics, type of tissue and biological indices. A computational model based on a proton spectrum and LET is used for the estimation of the biological dose. Methods: The depth dose curve of the pristine beam is divided into two regions: the proximal region from the surface to the Bragg peak and the distal region beyond the peak. Knowing the beam energy at the surface in the proximal region, and using the published energy‐range tables, we estimated the effective proton energy at any depth proximal to the Bragg peak. Based on the energy, the LET and RBE is estimated. In the distal region, we assume that the effective beam energy changes monotonically from the value calculated at the peak to the final energy of about 3MeV at the 3% dose level on the distal edge. Applying the calculated RBE factor to the measured depth dose profile we obtain the biological dose in the pristine beam. The method can easily be applied to modulated beams. Results: Our computation model shows that it is possible to predict the biological dose for any combination of beam energy, and for SOBP size based on the available RBE data. Our results showed that the biological dose for a SOBP has finite slope rising to higher values close to distal edge of the peak. Conclusions: A computational model provides an unique tool to estimate the biological dose in any combination of beam energy and SOBP size. If the RBE vs LET data for a tissue is know our computational approach could provide the biological dose accurately in a clinical beam.

AB - Purpose: The variability of relative biological effectiveness (RBE) of a proton beam with spatial distribution is well known. It is dependent on the proton beam characteristics, type of tissue and biological indices. A computational model based on a proton spectrum and LET is used for the estimation of the biological dose. Methods: The depth dose curve of the pristine beam is divided into two regions: the proximal region from the surface to the Bragg peak and the distal region beyond the peak. Knowing the beam energy at the surface in the proximal region, and using the published energy‐range tables, we estimated the effective proton energy at any depth proximal to the Bragg peak. Based on the energy, the LET and RBE is estimated. In the distal region, we assume that the effective beam energy changes monotonically from the value calculated at the peak to the final energy of about 3MeV at the 3% dose level on the distal edge. Applying the calculated RBE factor to the measured depth dose profile we obtain the biological dose in the pristine beam. The method can easily be applied to modulated beams. Results: Our computation model shows that it is possible to predict the biological dose for any combination of beam energy, and for SOBP size based on the available RBE data. Our results showed that the biological dose for a SOBP has finite slope rising to higher values close to distal edge of the peak. Conclusions: A computational model provides an unique tool to estimate the biological dose in any combination of beam energy and SOBP size. If the RBE vs LET data for a tissue is know our computational approach could provide the biological dose accurately in a clinical beam.

UR - http://www.scopus.com/inward/record.url?scp=85024783877&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024783877&partnerID=8YFLogxK

U2 - 10.1118/1.3611960

DO - 10.1118/1.3611960

M3 - Article

AN - SCOPUS:85024783877

VL - 38

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 6

ER -